InsidersTradesSigma
Track the Genscript Biotech Corporation share price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, Genscript Biotech Corporation has recorded 14 public disclosures. Market capitalisation: €75.4bn. The latest transaction was disclosed on 21 August 2026 (Sale). Among the most active insiders: Zhu Li. All data is accessible without an account.
14
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
€851,078
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genscript Biotech Corporation Strong Buy (bullish), based on 7 analysts. Average price target: HK$29.17.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,101 of 28,803 companies
33.2
score / 100
Value35
Quality31
FCF yld0.3%
Earn yld-0.7%
EV/EBITDA·
ROE-15%
Gross mgn58%
Net mgn-56%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2026
Declarations14 total
3,907,209 sharesShareXHKGHKEX:DA20260625E00322
7,693,304 sharesShareXHKGHKEX:DA20260625E00320
5,270,879 sharesShareXHKGHKEX:DA20260625E00318
313,650 shares@ HK$12.12060.0062% mcap95.1% of flowShareXHKGHKEX:DA20260609E00352
169,561 sharesShareXHKGHKEX:DA20260609E00356
113,041 sharesShareXHKGHKEX:DA20260609E00361
841,470 sharesShareXHKGHKEX:DA20260609E00353
16,071 shares@ HK$12.25080.0003% mcap100.0% of flowShareXHKGHKEX:DA20260410E00415
14 of 14 declarations
About Genscript Biotech Corporation
Genscript Biotech Corporation is a biotechnology company that provides research services and products for drug development. It is listed on the Hong Kong Stock Exchange.